9 news items
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
ABL
AGIO
AKAN
28 May 24
successfully transformed into a high-innovation and high growth company.
Oblong, Inc
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
ARCT
28 May 24
®) in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
ACHL
ARCT
22 May 24
. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
ARCT
CSLLY
20 May 24
President, Vaccines Innovation Unit, CSL.
"We are thrilled that the results of the ARCT-154 study have been
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
ARCT
CSLLY
20 May 24
Jon Edelman, M.D., Senior Vice President, Vaccines Innovation Unit, CSL
gez94czf5osqf5df2qq7ggu8hay2icas4rncmg15l
ARCT
15 May 24
for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics
mwl90pjvu k93gr0dbkgxsi04q0miptudn53xrjwmsspwau45fc5twbm
ARCT
8 May 24
to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS
ok27e937ml53wsvj66rv5ghesgt0syg0ddi4titz444abmoiw9fzxzh cg
ARCT
25 Apr 24
has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture
s43ynkt9t12ef6cdp
ARCT
7 Mar 24
an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture
- Prev
- 1
- Next